Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Brien JT[au]:

Search results

Items: 1 to 50 of 459

1.

Correlation of microglial activation with white matter changes in dementia with Lewy bodies.

Nicastro N, Mak E, Williams GB, Surendranathan A, Bevan-Jones WR, Passamonti L, Vàzquez Rodrìguez P, Su L, Arnold R, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT.

Neuroimage Clin. 2020 Jan 28;25:102200. doi: 10.1016/j.nicl.2020.102200. [Epub ahead of print]

2.

Microbleeds in dementia with Lewy bodies.

Donaghy PC, Firbank M, Mitra D, Petrides G, Lloyd J, Barnett N, Olsen K, Thomas AJ, O'Brien JT.

J Neurol. 2020 Feb 4. doi: 10.1007/s00415-020-09736-0. [Epub ahead of print]

PMID:
32016624
3.

Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies.

Donaghy PC, Firbank MJ, Thomas AJ, Lloyd J, Petrides G, Barnett N, Olsen K, O'Brien JT.

Am J Geriatr Psychiatry. 2019 Dec 23. pii: S1064-7481(19)30589-5. doi: 10.1016/j.jagp.2019.12.009. [Epub ahead of print]

PMID:
31953009
4.

Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly.

Zhang L, Mak E, Reilhac A, Shim HY, Ng KK, Ong MQW, Ji F, Chong EJY, Xu X, Wong ZX, Stephenson MC, Venketasubramanian N, Tan BY, O'Brien JT, Zhou JH, Chen CLH; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2020 Jan 14. doi: 10.1002/hbm.24928. [Epub ahead of print]

PMID:
31944479
5.

Deep learning-based automated speech detection as a marker of social functioning in late-life depression.

Little B, Alshabrawy O, Stow D, Ferrier IN, McNaney R, Jackson DG, Ladha K, Ladha C, Ploetz T, Bacardit J, Olivier P, Gallagher P, O'Brien JT.

Psychol Med. 2020 Jan 16:1-10. doi: 10.1017/S0033291719003994. [Epub ahead of print]

PMID:
31944174
6.

Uniformity of cardiac 123I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia.

Roberts G, Lloyd JJ, Jefferson E, Kane JPM, Durcan R, Lawley S, Petrides GS, Howe K, Haq I, O'Brien JT, Thomas AJ.

J Nucl Cardiol. 2019 Dec 9. doi: 10.1007/s12350-019-01977-5. [Epub ahead of print]

PMID:
31820410
7.

Weighted network measures reveal differences between dementia types: An EEG study.

Mehraram R, Kaiser M, Cromarty R, Graziadio S, O'Brien JT, Killen A, Taylor JP, Peraza LR.

Hum Brain Mapp. 2019 Dec 9. doi: 10.1002/hbm.24896. [Epub ahead of print]

PMID:
31816147
8.

Association between midlife dementia risk factors and longitudinal brain atrophy: the PREVENT-Dementia study.

O'Brien JT, Firbank MJ, Ritchie K, Wells K, Williams GB, Ritchie CW, Su L.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):158-161. doi: 10.1136/jnnp-2019-321652. Epub 2019 Dec 5.

PMID:
31806724
9.

Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia.

Colloby SJ, Watson R, Blamire AM, O'Brien JT, Taylor JP.

Aust N Z J Psychiatry. 2019 Nov 7:4867419885165. doi: 10.1177/0004867419885165. [Epub ahead of print]

PMID:
31696728
10.

Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features.

Low A, Mak E, Malpetti M, Chouliaras L, Nicastro N, Su L, Holland N, Rittman T, Rodríguez PV, Passamonti L, Bevan-Jones WR, Jones PS, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2019 Oct 1;11:690-699. doi: 10.1016/j.dadm.2019.08.001. eCollection 2019 Dec.

11.

18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy.

Nicastro N, Rodriguez PV, Malpetti M, Bevan-Jones WR, Simon Jones P, Passamonti L, Aigbirhio FI, O'Brien JT, Rowe JB.

J Neurol. 2020 Feb;267(2):341-349. doi: 10.1007/s00415-019-09566-9. Epub 2019 Oct 22.

12.

Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.

Roberts G, Lloyd JJ, Kane JPM, Durcan R, Lawley S, Howe K, Petrides GS, O'Brien JT, Thomas AJ.

J Nucl Cardiol. 2019 Sep 16. doi: 10.1007/s12350-019-01887-6. [Epub ahead of print]

PMID:
31529384
13.

New evidence on the management of Lewy body dementia.

Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O'Brien JT.

Lancet Neurol. 2020 Feb;19(2):157-169. doi: 10.1016/S1474-4422(19)30153-X. Epub 2019 Sep 10. Review.

PMID:
31519472
14.

11 C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia.

Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT.

Ann Clin Transl Neurol. 2019 Oct;6(10):2133-2136. doi: 10.1002/acn3.50877. Epub 2019 Sep 10.

15.

Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance.

Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O'Brien JT, Rowe JB.

J Neurosci. 2019 Sep 4;39(36):7218-7226. doi: 10.1523/JNEUROSCI.2574-18.2019. Epub 2019 Jul 18.

16.

Inflammation and cerebral small vessel disease: A systematic review.

Low A, Mak E, Rowe JB, Markus HS, O'Brien JT.

Ageing Res Rev. 2019 Aug;53:100916. doi: 10.1016/j.arr.2019.100916. Epub 2019 Jun 10. Review.

PMID:
31181331
17.

A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies.

Roberts G, Kane JPM, Lloyd JJ, Petrides GS, Howe K, O'Brien JT, Thomas AJ.

Nucl Med Commun. 2019 Jul;40(7):734-743. doi: 10.1097/MNM.0000000000001024.

PMID:
31058746
18.

Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer's disease and vascular dementia?

Savulich G, O'Brien JT, Sahakian BJ.

Br J Psychiatry. 2019 Apr 30:1-3. doi: 10.1192/bjp.2019.98. [Epub ahead of print]

PMID:
31036096
19.

Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis.

Schumacher J, Cromarty R, Gallagher P, Firbank MJ, Thomas AJ, Kaiser M, Blamire AM, O'Brien JT, Peraza LR, Taylor JP.

J Neurol. 2019 Jul;266(7):1716-1726. doi: 10.1007/s00415-019-09323-y. Epub 2019 Apr 21.

20.

Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease.

Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O'Brien JT, Blamire AM, Taylor JP.

Neuroimage Clin. 2019;22:101812. doi: 10.1016/j.nicl.2019.101812. Epub 2019 Apr 3.

21.

Dysfunctional brain dynamics and their origin in Lewy body dementia.

Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O'Brien JT, Blamire AM, Taylor JP.

Brain. 2019 Jun 1;142(6):1767-1782. doi: 10.1093/brain/awz069.

22.

Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease.

Sheikh-Bahaei N, Manavaki R, Sajjadi SA, Priest AN, O'Brien JT, Gillard JH.

J Alzheimers Dis. 2019;68(4):1489-1497. doi: 10.3233/JAD-180443.

PMID:
30909210
23.

Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies.

Durcan R, Donaghy PC, Barnett NA, Olsen K, Yarnall AJ, Taylor JP, McKeith I, O'Brien JT, Thomas AJ.

Int J Geriatr Psychiatry. 2019 Jul;34(7):990-998. doi: 10.1002/gps.5100. Epub 2019 Apr 24.

PMID:
30901488
24.

123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults.

Roberts G, Lloyd JJ, Petrides GS, Donaghy PC, Kane JPM, Durcan R, Lawley S, Howe K, Sims AJ, Taylor JP, O'Brien JT, Thomas AJ.

Ann Nucl Med. 2019 Jun;33(6):434-443. doi: 10.1007/s12149-019-01352-x. Epub 2019 Mar 21.

PMID:
30900103
25.

Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease.

King E, O'Brien JT, Donaghy P, Morris C, Barnett N, Olsen K, Martin-Ruiz C, Taylor JP, Thomas AJ.

Int Psychogeriatr. 2019 Apr;31(4):551-560. doi: 10.1017/S1041610218001126. Epub 2019 Mar 11.

PMID:
30854988
26.

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2019 Jan 2;6(2):373-378. doi: 10.1002/acn3.683. eCollection 2019 Feb.

27.

Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.

Wilkinson T, Schnier C, Bush K, Rannikmäe K, Henshall DE, Lerpiniere C, Allen NE, Flaig R, Russ TC, Bathgate D, Pal S, O'Brien JT, Sudlow CLM; Dementias Platform UK and UK Biobank.

Eur J Epidemiol. 2019 Jun;34(6):557-565. doi: 10.1007/s10654-019-00499-1. Epub 2019 Feb 26.

28.

Clinical Presentation, Diagnostic Features, and Mortality in Dementia with Lewy Bodies.

Moylett S, Price A, Cardinal RN, Aarsland D, Mueller C, Stewart R, O'Brien JT.

J Alzheimers Dis. 2019;67(3):995-1005. doi: 10.3233/JAD-180877.

PMID:
30776008
29.

123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort.

Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O'Brien JT, Thomas AJ.

Parkinsonism Relat Disord. 2019 May;62:79-84. doi: 10.1016/j.parkreldis.2019.01.024. Epub 2019 Jan 26.

PMID:
30709778
30.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O'Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV.

Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.

31.

Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies.

Mueller C, Soysal P, Rongve A, Isik AT, Thompson T, Maggi S, Smith L, Basso C, Stewart R, Ballard C, O'Brien JT, Aarsland D, Stubbs B, Veronese N.

Ageing Res Rev. 2019 Mar;50:72-80. doi: 10.1016/j.arr.2019.01.005. Epub 2019 Jan 6. Review.

PMID:
30625375
32.

Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Arnaoutoglou NA, O'Brien JT, Underwood BR.

Nat Rev Neurol. 2019 Feb;15(2):103-112. doi: 10.1038/s41582-018-0107-7. Review.

PMID:
30559465
33.

Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer's Disease.

Cromarty RA, Schumacher J, Graziadio S, Gallagher P, Killen A, Firbank MJ, Blamire A, Kaiser M, Thomas AJ, O'Brien JT, Peraza LR, Taylor JP.

Front Aging Neurosci. 2018 Oct 30;10:347. doi: 10.3389/fnagi.2018.00347. eCollection 2018.

34.

The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease.

FitzGerald JM, Perera G, Chang-Tave A, Price A, Rajkumar AP, Bhattarai M, O'Brien JT, Ballard C, Aarsland D, Stewart R, Mueller C.

J Am Med Dir Assoc. 2019 May;20(5):604-609. doi: 10.1016/j.jamda.2018.09.021. Epub 2018 Nov 15.

PMID:
30448339
35.

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2018 Sep 17;10:678-687. doi: 10.1016/j.dadm.2018.08.005. eCollection 2018.

36.

Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vázquez Rodríguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Brain. 2018 Dec 1;141(12):3415-3427. doi: 10.1093/brain/awy265.

37.

Management of visual hallucinations in dementia and Parkinson's disease.

Swann P, O'Brien JT.

Int Psychogeriatr. 2019 Jun;31(6):815-836. doi: 10.1017/S1041610218001400. Epub 2018 Nov 6.

PMID:
30398127
38.

[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion.

Bevan-Jones RW, Cope TE, Jones SP, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FA, Patterson K, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2018 Sep 14;5(10):1292-1296. doi: 10.1002/acn3.631. eCollection 2018 Oct.

39.

Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.

Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O'Brien JT.

Neurobiol Aging. 2019 Jan;73:74-81. doi: 10.1016/j.neurobiolaging.2018.09.004. Epub 2018 Sep 12.

PMID:
30339962
40.

A new visual rating scale for Ioflupane imaging in Lewy body disease.

Lloyd JJ, Petrides G, Donaghy PC, Colloby SJ, Attems J, O'Brien JT, Roberts G, Thomas AJ.

Neuroimage Clin. 2018;20:823-829. doi: 10.1016/j.nicl.2018.09.012. Epub 2018 Sep 20.

41.

Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.

Ritchie K, Carrière I, Howett D, Su L, Hornberger M, O'Brien JT, Ritchie CW, Chan D.

J Alzheimers Dis. 2018;65(3):885-896. doi: 10.3233/JAD-180432.

PMID:
30103333
42.

Ammon's Horn 2 (CA2) of the Hippocampus: A Long-Known Region with a New Potential Role in Neurodegeneration.

Pang CC, Kiecker C, O'Brien JT, Noble W, Chang RC.

Neuroscientist. 2019 Apr;25(2):167-180. doi: 10.1177/1073858418778747. Epub 2018 Jun 5. Review.

PMID:
29865938
43.

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications.

Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O'Brien JT, Ballard C, Stewart R, Aarsland D.

Alzheimers Dement (Amst). 2017 Dec 27;10:143-152. doi: 10.1016/j.dadm.2017.12.001. eCollection 2018.

44.

[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.

Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Neurology. 2018 May 29;90(22):e1989-e1996. doi: 10.1212/WNL.0000000000005610. Epub 2018 Apr 27.

45.

Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.

Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT.

J Neurol. 2018 Jul;265(7):1528-1539. doi: 10.1007/s00415-018-8873-0. Epub 2018 Apr 25.

PMID:
29696499
46.

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.

Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O'Brien JT.

Psychol Med. 2019 Feb;49(3):396-402. doi: 10.1017/S0033291718000995. Epub 2018 Apr 25.

47.

Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.

Donaghy PC, Firbank MJ, Thomas AJ, Lloyd J, Petrides G, Barnett N, Olsen K, O'Brien JT.

Mov Disord. 2018 Jul;33(7):1130-1138. doi: 10.1002/mds.27403. Epub 2018 Apr 19.

48.

Clinical imaging in dementia with Lewy bodies.

Surendranathan A, O'Brien JT.

Evid Based Ment Health. 2018 May;21(2):61-65. doi: 10.1136/eb-2017-102848. Epub 2018 Mar 29. Review.

PMID:
29602778
49.

Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer's disease patients.

Peraza LR, Cromarty R, Kobeleva X, Firbank MJ, Killen A, Graziadio S, Thomas AJ, O'Brien JT, Taylor JP.

Sci Rep. 2018 Mar 15;8(1):4637. doi: 10.1038/s41598-018-22984-5.

50.

Positron emission tomography-guided magnetic resonance spectroscopy in Alzheimer disease.

Sheikh-Bahaei N, Sajjadi SA, Manavaki R, McLean M, O'Brien JT, Gillard JH.

Ann Neurol. 2018 Apr;83(4):771-778. doi: 10.1002/ana.25202. Epub 2018 Apr 10.

PMID:
29518282

Supplemental Content

Loading ...
Support Center